Donald Hooker
Stock Analyst at Keybanc
(1.70)
# 2,100
Out of 4,415 analysts
58
Total ratings
58.43%
Success rate
11.32%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $12.78 | +682.47% | 12 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $233.47 | +67.05% | 4 | Feb 17, 2022 | |
| IQV IQVIA Holdings | Maintains: Overweight | n/a | $223.37 | - | 3 | Nov 17, 2021 | |
| DGX Quest Diagnostics | Maintains: Overweight | n/a | $137.38 | - | 2 | Sep 1, 2021 | |
| PHR Phreesia | Maintains: Overweight | n/a | $22.32 | - | 4 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | n/a | $8.84 | - | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $0.57 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | n/a | $203.45 | - | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $79.75 | - | 7 | Dec 2, 2020 | |
| RCM R1 RCM | Maintains: Overweight | n/a | $12.47 | - | 1 | Jul 14, 2020 | |
| EVH Evolent Health | Downgrades: Sector Weight | n/a | $27.10 | - | 7 | Jul 6, 2020 | |
| MMS Maximus | Upgrades: Overweight | n/a | $82.81 | - | 1 | Jun 24, 2020 | |
| LH Laboratory Corporation of America Holdings | Maintains: Overweight | n/a | $201.32 | - | 4 | Mar 30, 2020 | |
| MDRX Veradigm | Downgrades: Sector Weight | n/a | $7.70 | - | 2 | Feb 22, 2019 | |
| ICLR ICON PLC | Maintains: Overweight | n/a | $309.02 | - | 3 | Sep 11, 2018 | |
| INCR InterCure | Maintains: Overweight | n/a | $3.12 | - | 2 | Nov 13, 2017 | |
| PINC Premier | Downgrades: Sector Weight | n/a | $21.22 | - | 1 | Oct 24, 2017 | |
| MEDP Medpace Holdings | Downgrades: Sector Weight | n/a | $392.57 | - | 1 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $12.78
Upside: +682.47%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $233.47
Upside: +67.05%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: n/a
Current: $223.37
Upside: -
Quest Diagnostics
Sep 1, 2021
Maintains: Overweight
Price Target: n/a
Current: $137.38
Upside: -
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: n/a
Current: $22.32
Upside: -
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: n/a
Current: $8.84
Upside: -
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $0.57
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: n/a
Current: $203.45
Upside: -
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $79.75
Upside: -
R1 RCM
Jul 14, 2020
Maintains: Overweight
Price Target: n/a
Current: $12.47
Upside: -
Evolent Health
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $27.10
Upside: -
Maximus
Jun 24, 2020
Upgrades: Overweight
Price Target: n/a
Current: $82.81
Upside: -
Laboratory Corporation of America Holdings
Mar 30, 2020
Maintains: Overweight
Price Target: n/a
Current: $201.32
Upside: -
Veradigm
Feb 22, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $7.70
Upside: -
ICON PLC
Sep 11, 2018
Maintains: Overweight
Price Target: n/a
Current: $309.02
Upside: -
InterCure
Nov 13, 2017
Maintains: Overweight
Price Target: n/a
Current: $3.12
Upside: -
Premier
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $21.22
Upside: -
Medpace Holdings
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $392.57
Upside: -